Annai Systems to Power Genomic Medicine for Oncologists Through Acquisition of MedTrust Online
LOS GATOS, CA – May 31, 2012 – Annai Systems Inc., a private company that develops and deploys high-performance network technology for genomic research and medicine, announced that it has completed the acquisition of MedTrust Online LLC — the world’s largest on-line community of oncologists — through an asset-purchase transaction. For over three years, MedTrust has delivered timely information about the latest diagnostic and treatment options, as well as informal consultation by its panel of experts, to a registry of more than 10,000 oncologists worldwide—including the vast majority of those in the United States.
“We have clear evidence that oncologists in the MedTrust community are increasingly determined to incorporate genomic insights into the diagnosis and treatment of cancer and have an expanding appetite for the data, knowledge, expertise, and services that enable them to do so,” said Chris Yoo, Ph.D., formerly CEO of MedTrust and now Senior Vice President of Business Development for Annai. “Powered by the genome network technology of Annai, the MedTrust portal will soon enable individual oncologists to realize the highest levels of precision care for their patients through direct access to the full ecosystem of genomic research and medicine.”
“For Annai, the MedTrust transaction represents another major step in building end-to-end, network infrastructure that enables the multi-lateral flow of genomic data and knowledge between individuals and communities in research and medicine,” said Annai’s CEO, Lawrence Ganeshalingam. “This is a key cornerstone of the Annai vision.”
Last month, Annai announced that it had licensed its network operating system (Annai-GNOSTM) to the University of California, Santa Cruz for operation of a large new data repository in which the Annai system will enable storage, management and high-speed distribution of genomic and other Big Data from the major research initiatives of the National Cancer Institute, including The Cancer Genome Atlas (TCGA).
About Annai Systems
Annai Systems is a leading genomic data analysis company committed to developing cost-reducing innovations the accelerate scientific discovery, maximize statistical power, and optimize data control. From data compression and storage to secondary and tertiary analysis, Annai Systems offers a true end-to-end solution designed to handle the complex needs of next-generation sequencing data in the clinical, pharmaceutical and research environments. The company’s flagship product, STARPlatform, enables researchers to innovate, collaborate, and make new discoveries – all in less time and at lower costs than traditional solutions. For more about Annai Systems, visit www.annaisystems.com.